Cumulative metformin linked to mortality post-prostate cancer
(HealthDay)—Among elderly men with diabetes, increased cumulative duration of metformin following a prostate cancer (PC) diagnosis correlates with decreased all-cause and PC-specific mortality, according to a study published ...
Aug 8, 2013
0
0